Infinitus (China) Company has secured approval for its Sino-British Joint Laboratory on Health and Ageing project. This initiative is part of the intergovernmental international science and technology cooperation under China's National Key R&D Program. The approval marks a crucial advancement in Infinitus's pursuit of international scientific research and signifies a major breakthrough in spearheading national projects.
Infinitus, a frontrunner in the Chinese herbal medicine industry, blends traditional Eastern wellness wisdom with modern methodologies, pioneering innovative approaches to studying delayed aging through herbal science and technology. The University of Cambridge in the UK, known for its deep expertise in biology and genetics, stands at the forefront of global technology and scientific research. Meanwhile, the South China University of Technology boasts extensive academic knowledge in food science and nutrition, supported by a team of research professionals.
Together, the team is focused on the field of prolonged ageing, advancing the innovative integration of Chinese herbal medicine with contemporary techniques and providing substantial support for the advancement and global integration of traditional Chinese medicine.
Infinitus's approval for this project is the result of its extensive experience in scientific research over the years. Since initiating its collaboration with the University of Cambridge and South China University of Technology a decade ago, Infinitus has concentrated on research in delayed ageing, amassing significant scientific data and findings that provided a robust foundation for the project's approval.
In December 2023, Infinitus and the two collaborating institutions submitted an application for the National Key R&D Program to China's Ministry of Science and Technology. Following rigorous reviews, expert evaluations, and bilateral consultations between the Chinese and British governments, the project secured approval at the end of 2024.
